Feng Chi Biotech Corp. provides prenatal testing, new born screening, life science and microbiological testing services. The company was founded on May 12, 1992 and is headquartered in Taipei, Taiwan.
6744 stock has fallen by 0.22% compared to the previous week, the month change is a 2.22% rise, over the last year FENG CHI BIOTECH CORP has showed a 19.72% decrease.
6744 net income for the last quarter is 9.49 M TWD, while the quarter before that showed 13.30 M TWD of net income which accounts for −28.68% change. Track more FENG CHI BIOTECH CORP financial stats to get the full picture.
Today FENG CHI BIOTECH CORP has the market capitalization of 337.87 M, it has decreased by 0.22% over the last week.
Yes, 6744 dividends are paid annually. The last dividend per share was 1.35 TWD. As of today, Dividend Yield (TTM)% is 5.87%. Tracking FENG CHI BIOTECH CORP dividends might help you take more informed decisions.
FENG CHI BIOTECH CORP dividend yield was 4.73% in 2023, and payout ratio reached 70.95%. The year before the numbers were 6.75% and 84.46% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 6744 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FENG CHI BIOTECH CORP stock right from TradingView charts — choose your broker and connect to your account.
6744 reached its all-time high on May 25, 2020 with the price of 71.00 TWD, and its all-time low was 18.00 TWD and was reached on Nov 11, 2022. See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So FENG CHI BIOTECH CORP technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating FENG CHI BIOTECH CORP stock shows the sell signal. See more of FENG CHI BIOTECH CORP technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. FENG CHI BIOTECH CORP EBITDA is 31.38 M TWD, and current EBITDA margin is 17.38%. See more stats in FENG CHI BIOTECH CORP financial statements.